-
February 23: The Week in Cancer News
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.
by Thomas Celona
-
February 16: The Week in Cancer News
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
by Kevin McLaughlin
-
February 9: The Week in Cancer News
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.
by Marci A. Landsmann
-
February 2: The Week in Cancer News
Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.
by Eric Fitzsimmons
-
January 26: The Week in Cancer News
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.
by Thomas Celona
-
January 19: The Week in Cancer News
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
by Eric Fitzsimmons
-
January 12: The Week in Cancer News
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
by Kevin McLaughlin
-
January 5: The Week in Cancer News
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
by Marci A. Landsmann
-
December 15: The Week in Cancer News
Study finds breast cancer survivors can opt for less frequent screening, and people with physical disabilities often encounter discrimination in cancer care.
by Thomas Celona
-
December 8: The Week in Cancer News
Less radiation explored in multiple studies at San Antonio Breast Cancer Symposium, and National Cancer Institute writes next precision medicine chapter.
by Marci A. Landsmann
Cancer Talk
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
Navigating Out of Financial ToxicityPeople with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona
Taking Answers HomeAdvocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
Lifestyle Choices and CancerWhat people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin